Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by Pareto8020on Aug 06, 2020 2:07pm
170 Views
Post# 31374331

R&F product launch.... or is it a failure to launch?

R&F product launch.... or is it a failure to launch?I wonder what R&F's idea of "up and coming" converts to in years or months?  Here we are 11 months since this deal was announced and zippo TFC-1067 in any retail product yet.  If it isn't included in the next launch this deal is about as good as SBM's current shareprice which is now equivalent to what it was trading at in 2016. 

The share price clearly shows that SBM hasn't had the right PR company (or management in some cases) on board since a reputable company would have built up their share price as SBM built up their pipeline and moved compounds to market ready status.  There is no momentum behind SBM and ironically they are using Momentum PR to try and do just that.  Only thing that will be moving SBM shareprice now are revenue$$$.     



“As a company committed to innovation, Rodan + Fields continually seeks out novel and groundbreaking technologies. We’re excited to partner with Sirona to commercialize this highly novel new molecule in an up-and-coming product release and deliver the well-validated benefits to our consumer base”, said Dr. Simon Craw, Senior Director of R&D Read more here...

https://www.sironabiochem.com/sirona-biochem-signs-definitive-license-supply-agreement-with-skincare-industry-leader-rodan-fields/


<< Previous
Bullboard Posts
Next >>